text
stringlengths
0
1.95M
various stock option plans. That cost is expected to be recognized during the remaining periods of 2023 and 2024. 20 Zion
Oil & Gas, Inc. Consolidated
Condensed Notes to Financial Statements (Unaudited) Note
3 - Stockholders’ Equity (cont’d) D.
Dividend Reinvestment and Stock Purchase Plan (“DSPP”) On
March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with
the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014.
On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration
No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The
Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed
and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and
replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336. On
March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders
and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly
from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original
Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration
Statement on Form S-3, as thereafter amended. On
January 13, 2015, the Company amended the Original Prospectus Supplement (“Amendment No. 3”) to provide for a unit option
(the “Unit Option”) under the DSPP comprised of one share of Common Stock and three Common Stock purchase warrants with each
unit priced at $ 4.00 . Each warrant afforded the participant the opportunity to purchase the Company’s Common Stock at a warrant
exercise price of $ 1.00 . Each of the three warrants series had different expiration dates that had been extended. The
ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018,
at a per share exercise price of $ 1.00 . As
of May 2, 2017, any outstanding ZNWAB warrants expired. As
of May 2, 2018, any outstanding ZNWAC warrants expired. On
May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020
to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On
September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2,
2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension. As
of May 2, 2023, any outstanding ZNWAD warrants expired. On
November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units
comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $ 10 . The warrant
is referred to as “ZNWAE.” The
ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of
$ 1.00 . On
May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one ( 1 ) year from the expiration date of May 1, 2020
to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On
September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two ( 2 ) years from the expiration date of May 1,
2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension. 21 Zion
Oil & Gas, Inc. Consolidated
Condensed Notes to Financial Statements (Unaudited) Note
3 - Stockholders’ Equity (cont’d) As
of May 1, 2023, any outstanding ZNWAE warrants expired. On
May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants,
a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions
and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase
Units of the Company’s securities where each Unit (priced at $ 250.00 each) was comprised of (i) the number of shares of Common
Stock determined by dividing $ 250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common
Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares
of Common Stock at a warrant exercise price of $ 1.00 per share. The warrant is referred to as “ZNWAF.” All
ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise
price of $ 1.00 . On
May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020
to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this
extension. On
September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August
14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension. As
of August 14, 2023, any outstanding ZNWAF warrants expired. An
Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under
Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants
to purchase Units of the Company’s securities where each Unit (priced at $ 250.00 each) was comprised of (i) a certain number of
shares of Common Stock determined by dividing $ 250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s
Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $ 1.00 per share. The warrant is referred to as “ZNWAG.” The warrants became exercisable on January 8,
2018 and continue to be exercisable through January 8, 2023 at a revised per share exercise price of $ .25 . The warrant terms provide that
if the Company’s Common Stock trades above $ 5.00 per share as the closing price for 15 consecutive trading days at any time prior
to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing
60 days advanced notice to the warrant holders. 22 Zion
Oil & Gas, Inc. Consolidated
Condensed Notes to Financial Statements (Unaudited) Note
3 - Stockholders’ Equity (cont’d) On
December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January
8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned
to this extension. On
February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units
of our securities where each Unit (priced at $ 250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase
warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares
of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase
one share of Company Common Stock at a warrant exercise price of $ 5.00 . The warrant is referred to as “ZNWAH.” The
warrants became exercisable on April 2, 2018 and continued to be exercisable through April 2, 2020 at a per share exercise price of $ 5.00 ,
after the Company, on December 4, 2018, extended the termination date of the Warrant by one ( 1 ) year from the expiration date of April
2, 2019 to April 2, 2020. On
May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one ( 1 ) year from the expiration date of April 2, 2020
to April 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On
September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two ( 2 ) years from the expiration date of April
2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to
this extension. As
of April 2, 2023, any outstanding ZNWAH warrants expired. On
August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units
of the Company’s securities where each Unit (priced at $ 250.00 each) was comprised of (i) a certain number of shares of Common
Stock determined by dividing $ 250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly
traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional
twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s
Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common
Stock at a warrant exercise price of $ 1.00 . The warrant is referred to as “ZNWAJ.” The
warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price
of $ 1 .00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date
of October 29, 2019 to October 29, 2020. On